As the HSP90 inhibitor 17-AAG has recently been reported to reduce EGFR and IGF-IR expression in the bronchopulmonary typical carcinoid cell line NCI-H727 (13,15), we examined the effect of AUY922 and HSP990 on ErbB and IGF-I receptor expression. Here, EGFR is linked to carcinoid tumor.